Cited 0 times in
No Change of Pneumocystis jirovecii Pneumonia after the COVID-19 Pandemic: Multicenter Time-Series Analyses
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 김대영 | - |
dc.contributor.author | 이경화 | - |
dc.contributor.author | 이혜선 | - |
dc.contributor.author | 한상훈 | - |
dc.contributor.author | 김수빈 | - |
dc.date.accessioned | 2021-12-28T17:44:13Z | - |
dc.date.available | 2021-12-28T17:44:13Z | - |
dc.date.issued | 2021-11 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/187246 | - |
dc.description.abstract | Consolidated infection control measures imposed by the government and hospitals during COVID-19 pandemic resulted in a sharp decline of respiratory viruses. Based on the issue of whether Pneumocystis jirovecii could be transmitted by airborne and acquired from the environment, we assessed changes in P. jirovecii pneumonia (PCP) cases in a hospital setting before and after COVID-19. We retrospectively collected data of PCP-confirmed inpatients aged ≥18 years (N = 2922) in four university-affiliated hospitals between January 2015 and June 2021. The index and intervention dates were defined as the first time of P. jirovecii diagnosis and January 2020, respectively. We predicted PCP cases for post-COVID-19 and obtained the difference (residuals) between forecasted and observed cases using the autoregressive integrated moving average (ARIMA) and the Bayesian structural time-series (BSTS) models. Overall, the average of observed PCP cases per month in each year were 36.1 and 47.3 for pre- and post-COVID-19, respectively. The estimate for residuals in the ARIMA model was not significantly different in the total PCP-confirmed inpatients (7.4%, p = 0.765). The forecasted PCP cases by the BSTS model were not significantly different from the observed cases in the post-COVID-19 (-0.6%, 95% credible interval; -9.6~9.1%, p = 0.450). The unprecedented strict non-pharmacological interventions did not affect PCP cases. | - |
dc.description.statementOfResponsibility | open | - |
dc.format | application/pdf | - |
dc.language | English | - |
dc.publisher | MDPI | - |
dc.relation.isPartOf | JOURNAL OF FUNGI | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.title | No Change of Pneumocystis jirovecii Pneumonia after the COVID-19 Pandemic: Multicenter Time-Series Analyses | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Internal Medicine (내과학교실) | - |
dc.contributor.googleauthor | Dayeong Kim | - |
dc.contributor.googleauthor | Sun Bean Kim | - |
dc.contributor.googleauthor | Soyoung Jeon | - |
dc.contributor.googleauthor | Subin Kim | - |
dc.contributor.googleauthor | Kyoung Hwa Lee | - |
dc.contributor.googleauthor | Hye Sun Lee | - |
dc.contributor.googleauthor | Sang Hoon Han | - |
dc.identifier.doi | 10.3390/jof7110990 | - |
dc.contributor.localId | A05995 | - |
dc.contributor.localId | A04620 | - |
dc.contributor.localId | A03312 | - |
dc.contributor.localId | A04286 | - |
dc.relation.journalcode | J04005 | - |
dc.identifier.eissn | 2309-608X | - |
dc.identifier.pmid | 34829277 | - |
dc.subject.keyword | COVID-19 | - |
dc.subject.keyword | Pneumocystis jirovecii | - |
dc.subject.keyword | non-pharmacological interventions | - |
dc.subject.keyword | pandemic | - |
dc.subject.keyword | time-series analysis | - |
dc.contributor.alternativeName | Kim, Dae-Young | - |
dc.contributor.affiliatedAuthor | 김대영 | - |
dc.contributor.affiliatedAuthor | 이경화 | - |
dc.contributor.affiliatedAuthor | 이혜선 | - |
dc.contributor.affiliatedAuthor | 한상훈 | - |
dc.citation.volume | 7 | - |
dc.citation.number | 11 | - |
dc.citation.startPage | 990 | - |
dc.identifier.bibliographicCitation | JOURNAL OF FUNGI, Vol.7(11) : 990, 2021-11 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.